These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 5213242)

  • 1. Multiple myeloma. Prolonged periods of remission can be produced in myelomatosis with alkylating agents.
    Leone LA; Albala MM
    R I Med J; 1965 Sep; 48(9):478-85. PubMed ID: 5213242
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients.
    Matzner Y; Benbassat J; Polliack A
    Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296
    [No Abstract]   [Full Text] [Related]  

  • 3. A progress report on the Medical Research Council's therapeutic trial in myelomatosis.
    Galton DA; Peto R
    Br J Haematol; 1968 Sep; 15(3):319-20. PubMed ID: 5696221
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute myelogenous leukemia in myelomatosis].
    Tidsskr Nor Laegeforen; 1977 Feb; 97(4):175-7. PubMed ID: 265102
    [No Abstract]   [Full Text] [Related]  

  • 5. Myelomatosis: comparison of melphalan and cyclophosphamide therapy.
    Br Med J; 1971 Mar; 1(5750):640-1. PubMed ID: 4926948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognosis of Kahler's disease in patients treated and not treated with alkylating agents (apropos of 45 cases)].
    Saporta L; Hugon C; Rondier J; Bontoux D; Delbarre F
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):11-8. PubMed ID: 5079686
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prognosis in myelomatosis treated with prednisone and cytostatics].
    Hansen OP; Jessen B; Videbaek A
    Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Melphalan therapy in Myelomatosis].
    Ota H; Ikeda Y; Shibata T; Hattori H; Yasuma A
    Rinsho Ketsueki; 1972 Oct; 13(5):811-9. PubMed ID: 4674857
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of myelomatosis with melphalan (author's transl)].
    Hasegawa M; Aoki M; Ogawa T; Imamura Y; Hino S
    Rinsho Ketsueki; 1977 Aug; 18(8):961-72. PubMed ID: 916219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical aspects of multiple myeloma and its treatment based on a 10-year clinical experience].
    Bach I
    Orv Hetil; 1972 Apr; 113(17):981-5. PubMed ID: 5022591
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experiences with chemotherapy in patients with plasmacytoma].
    Sedlácková M; Libánský J
    Vnitr Lek; 1975 Nov; 21(11):1118-24. PubMed ID: 1198957
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiation.
    Hunter HM; Peggs K; Powles R; Rahemtulla A; Mahendra P; Cavenagh J; Littlewood T; Potter M; Hunter A; Pagliuca A; Williams CD; Cook G; Towlson K; Marks David I; Russell NH;
    Br J Haematol; 2005 Feb; 128(4):496-502. PubMed ID: 15686458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myelomatosis--diagnosis and treatment].
    Wester PO
    Lakartidningen; 1973 Feb; 70(6):475-8. PubMed ID: 4683688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of myelomatosis with melphalan and testosterone. Some biochemical changes in relation to therapeutics].
    Rordam P; Thiessen B
    Folia Clin Int (Barc); 1966; 16(7):339-41. PubMed ID: 5991648
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combination chemotherapy (modified M-2 protocol) for multiple myeloma].
    Iwata Y; Karitani Y; Tanaka I; Kobayashi T; Ohno T; Kageyama S; Katayama N; Kataoka Y; Kamio N; Ohota C
    Rinsho Ketsueki; 1984 Sep; 25(9):1380-7. PubMed ID: 6549187
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term treatment of myelomatosis with Melphalan and testosterone propionate].
    Rordam P
    Folia Clin Int (Barc); 1967 Mar; 17(3):148-58. PubMed ID: 5614470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined cytostatic therapy of plasmacytoma].
    Albert P; Zsuzsa M
    Orv Hetil; 1977 Jul; 118(31):1855-6. PubMed ID: 887257
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].
    Bontoux D; Chenbit D; Delbarre F
    Therapeutique; 1971 Jan; 47(1):27-32. PubMed ID: 5572915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rules of current therapy in multiple myeloma].
    Sonntag RW
    Schweiz Med Wochenschr; 1973 Sep; 103(38):1324-9. PubMed ID: 4763749
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
    Azam L; Delamore IW
    Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.